1. Home
  2. PTCT vs NVST Comparison

PTCT vs NVST Comparison

Compare PTCT & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • NVST
  • Stock Information
  • Founded
  • PTCT 1998
  • NVST 2018
  • Country
  • PTCT United States
  • NVST United States
  • Employees
  • PTCT N/A
  • NVST N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • NVST Medical/Dental Instruments
  • Sector
  • PTCT Health Care
  • NVST Health Care
  • Exchange
  • PTCT Nasdaq
  • NVST Nasdaq
  • Market Cap
  • PTCT 4.1B
  • NVST 3.4B
  • IPO Year
  • PTCT 2013
  • NVST 2019
  • Fundamental
  • Price
  • PTCT $61.09
  • NVST $21.01
  • Analyst Decision
  • PTCT Buy
  • NVST Buy
  • Analyst Count
  • PTCT 14
  • NVST 12
  • Target Price
  • PTCT $67.00
  • NVST $20.91
  • AVG Volume (30 Days)
  • PTCT 1.4M
  • NVST 1.5M
  • Earning Date
  • PTCT 11-06-2025
  • NVST 10-29-2025
  • Dividend Yield
  • PTCT N/A
  • NVST N/A
  • EPS Growth
  • PTCT N/A
  • NVST N/A
  • EPS
  • PTCT 7.72
  • NVST 0.31
  • Revenue
  • PTCT $1,764,929,000.00
  • NVST $2,552,900,000.00
  • Revenue This Year
  • PTCT $119.89
  • NVST $6.55
  • Revenue Next Year
  • PTCT N/A
  • NVST $3.33
  • P/E Ratio
  • PTCT $7.91
  • NVST $67.36
  • Revenue Growth
  • PTCT 96.00
  • NVST 0.76
  • 52 Week Low
  • PTCT $31.80
  • NVST $14.22
  • 52 Week High
  • PTCT $62.18
  • NVST $23.00
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 75.37
  • NVST 51.88
  • Support Level
  • PTCT $57.47
  • NVST $20.60
  • Resistance Level
  • PTCT $58.73
  • NVST $21.63
  • Average True Range (ATR)
  • PTCT 2.04
  • NVST 0.56
  • MACD
  • PTCT 0.96
  • NVST -0.02
  • Stochastic Oscillator
  • PTCT 92.16
  • NVST 60.19

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Share on Social Networks: